Management Forum Logo

Presented by
Management Forum

Metered Dose Inhaler (MDI) Technology Training Course

A comprehensive overview of MDIs including development, manufacture, regulation and market potential

★★★★★ "Mr. David has an amazing teaching skill, making complex content accessible (even for a non-native sp... more"

20-21 June 2024
+ 9-10 October 2024 »

from £1099

Need help?  Enrol or reserve

Course overview

This interactive course will provide a comprehensive overview of metered-dose inhaler technology past, present and future, giving participants a valuable insight into market potential and recent industry trends. The programme will clarify the therapeutic targets and look at the various delivery technologies available. There will be detailed coverage of the current environmental, regulatory and economic pressures and how these impact, development, manufacturing process, equipment and options, together with quality and inspection requirements, human factors and bioequivalence. Our highly experienced trainer will address the regulations applying to inhalation products and provide guidance on the regulatory pathways to follow.

The event will benefit those new to this area and will also be of value to anybody who requires a refresher on the opportunities available with this technology. The seminar format will include practical workshops, which past delegates have found invaluable, and ample opportunity for discussion on any specific issues with an expert in this field.

This course is of our range of Medical Devices training courses - now also including Medical Devices Cyber Security training to help improve your data security.

Who should attend?

  • Respiratory pharma professionals who need to understand MDI technology and its opportunities
  • Medical device professionals new to working in the area of MDIs or those who need a refresher
  • Development and regulatory professionals, with a development or product portfolio including MDIs, who need an understanding of future demands
  • Medical device business development managers
  • Respiratory professionals in R&D
  • Medical device manufacturers working in the respiratory market

Enrol or reserve

The Metered Dose Inhaler (MDI) Technology course will cover:

Therapeutic targets

  • A brief history of inhalation and MDI therapy
  • The lung as a target
  • Respiratory diseases
  • Systemic delivery
  • Therapeutic considerations
  • Life limiting Vs Life threatening

Markets past, present and future

  • Geographic - Challenges and opportunities
  • Disease prevalence
  • Economic considerations
  • International demand
  • Modelling opportunity (what to consider)

MDI Technology

  • How and Why MDIs work
  • MDI Formulation approaches
  • The elements of an MDI
  • Key performance characteristics
  • MDI Feature/ Functions compared to other dosage forms
  • Add-On technologies for MDIs
  • Are there limits to MDI technology?

Workshop I

  • Ranking of competitive technologies for different opportunities

MDI Manufacture

  • Key Process steps (space, services, staff)
  • Environment (Controls)
  • Equipment (Scale, design, options etc.)
  • Process controls & Inspection
  • Safety and Quality
  • Quality by Design (QbD) approaches
  • Manufacturing and cost

MDI Testing

  • What and when to test
  • How to test
  • How not to test
  • Demonstrating equivalence

Regulation of MDIs

  • Legislation
  • Regulatory guidance
  • Consensus standards
  • Pharmacopoeial requirements

Developing an MDI

  • The MDI as a drug-device combination product
  • Applying Design Controls
  • Human Factors & Usability
  • Risk management

Workshop II

  • SWOT MDI vs multi-dose DPI
  • SWOT MDI vs soft mist inhaler

MDIs and the environment

  • Inhaler Carbon Footprint
  • Environmental pressures on MDIs
  • Alternate propellants (Alternate problems?)
  • Alternate design approaches
  • Recycling - Technical and patient considerations

The future of the MDI

  • Summary of the Course
  • What opportunities does the future hold?
  • Workshop

Enrol or reserve

David Howlett
Pharma Delivery Solutions

In 2003 David established PharmaDelivery Solutions Ltd as a specialised consultancy service in the field of drug delivery combination products (especially respiratory) device technology. This has led to involvement in projects with focus in pulmonary, nasal and other delivery routes, with an international client base. Much of the activity of PharmaDelivery Solutions Ltd is focused in the area of development programme support, regulatory GAP analysis and generation of documentation supporting development and test programmes, together with data review and contingency evaluation.

David has over 35 years experience in the development, industrialization and approval of inhalation drug delivery systems, combination products and medical devices.

PharmaDelivery Solutions Ltd has provided input ranging from GAP analysis and comment to complete remedial implementation in areas including

• Design Control
• Risk Management
• Materials strategies
• Regulatory documentation
• Technical reviews and opinion

In addition to activities supporting commercial organizations, David has been involved in the following roles;

Honorary Teaching Fellow in the School of Pharmacy and Pharmaceutical Sciences at the University of Manchester and is author/ tutor for the Pharmaceutical Industry Advanced Training (PIAT) MSc module on Inhalation dosage forms.

A UK national expert representing the British Standards Institute on ISO TC84 developing new international standards for pulmonary and nasal delivery devices syringes and catheters.

David has also worked with the United Nations and various national governments to develop and establish transition strategies from the use of CFC in Metered Dose Inhalers and to secure appropriate budgets from the Multi-lateral fun for the implementation of the Montreal Protocol in emerging markets around the world.

More details

NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:

  • 30% off the 2nd delegate*
  • 40% off the 3rd delegate*
  • 50% off the 4th delegate*

Please contact us for pricing if you are interested in booking 5 or more delegates

20-21 June 2024

Live online

09:30-17:15 UK (London) (UTC+01)
10:30-18:15 Paris (UTC+02)
04:30-12:15 New York (UTC-04)
Course code 13705

  • GBP 1,099 1,299
  • EUR 1,589 1,869
  • USD 1,817 2,129

Until 16 May

View basket 

Not ready to book yet?

for 7 days, no obligation

9-10 October 2024

Live online

09:30-17:15 UK (London) (UTC+01)
10:30-18:15 Paris (UTC+02)
04:30-12:15 New York (UTC-04)
Course code 13879

  • GBP 1,099 1,299
  • EUR 1,589 1,869
  • USD 1,817 2,129

Until 04 Sep

View basket 

Not ready to book yet?

for 7 days, no obligation

* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.

Reviews of IPI's Metered Dose Inhaler (MDI) Technology training course

The material was very informative and presented by David in a way that was easy to understand, with good diagrams and analogies that helped with the understanding. Good balance of the technical aspects, history and options for the future.

Feb 26 2024

Simon Barton
Director - Device CoE, AstraZeneca

Mar 27 2023

Mr. David has an amazing teaching skill, making complex content accessible (even for a non-native speaker as I am).

Victor Panzeri
R&D Analyst, Eurofarma Laboratórios SA

Sep 18 2019

I was hoping for further improvement of my understanding of the matter of inhalational drugs, especially MDI, and this expectation was fully met. The speakers had superb knowledge of the subject, vast experience and a great sense of humour.

Robin Boehm
Team Leader Regulatory Submissions - New Products, STADA Arzneimittel AG

Feb 20 2019

In general good for content and presentation.

Celestino Ronchi
President, Delim Cosmetics & Pharma s.r.l.

Feb 20 2019

Very good course for those who has no previous experience in this Topic...Thanks to the organisers.

Sami Qassim
Senior Vice President , Tabuk Pharmaceutical Research Co.

United Kingdom

  • 3M
  • AstraZeneca
  • Avillion LLP
  • Chiesi Ltd
  • Chiesi SA
  • Lupin Healthcare UK
  • Medicines and Healthcare Products Regulatory Agency (MHRA)
  • MHRA
  • Presspart Manufacturing Limited
  • Presspart Manufacturing Ltd
  • Vectura


  • Eurofarma Laboratórios SA
  • Geolab Pharmaceutical Industry


  • AstraZeneca


  • RPC Formatec GmbH
  • STADA Arzneimittel AG


  • Delim Cosmetics & Pharma s.r.l.


  • H&T Presspart
  • Presspart

United States of America

  • AstraZeneca
  • Glenmark Pharma


  • Croatian Agency for Medicinal Products and Medical Devices


  • Teva Pharmaceuticals Ireland


  • Tabuk Pharmaceutical Research Co.

Enrol or reserve

Run Metered Dose Inhaler (MDI) Technology Live online for your team

2 days

Typical duration

Pricing from:

  • GBP 800
  • Per attendee, based on 10 attendees
  • Course tailored to your requirements
  • At your choice of location, or online


We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.

Contact our in-house training experts Aleksandra Beer and Yesim Nurko to discuss your requirements:

Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to:

Run this course conveniently and cost-effectively in-house for your staff and colleagues

Aleksandra Beer

Aleksandra BEER
Training expert

Yesim Nurko

Training expert

+44 (0)20 7749 4749